Clinical Trials
5
Trial Phases
2 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (5 trials with phase data)• Click on a phase to view related trials
Applying Platelet Rich Plasma (PRP) Gel to Acute Deep Partial Thickness Thermal Injuries
- Conditions
- Acute Deep Partial Thickness Thermal Burns
- First Posted Date
- 2014-06-23
- Last Posted Date
- 2017-04-13
- Lead Sponsor
- Arteriocyte, Inc.
- Target Recruit Count
- 36
- Registration Number
- NCT02169362
- Locations
- 🇺🇸
Arizona Burn Center, Phoenix, Arizona, United States
🇺🇸University of California, Davis Medica Center, Sacramento, California, United States
🇺🇸MedStar Health Research Institute, Washington, District of Columbia, United States
Registry Trial of the Effectiveness of Platelet Rich Plasma for Chronic Non-Healing Wounds
- Conditions
- Diabetic Foot UlcersPressure UlcersVenous Ulcers
- First Posted Date
- 2014-02-26
- Last Posted Date
- 2018-01-16
- Lead Sponsor
- Arteriocyte, Inc.
- Target Recruit Count
- 1500
- Registration Number
- NCT02071979
- Locations
- 🇺🇸
Good Samaritan Wound Care Center, Bakersfield, California, United States
🇺🇸Sunnyside Foot and Ankle, Idaho Falls, Idaho, United States
🇺🇸Wound Care Center, Englewood Hospital and Medical Center, Englewood, New Jersey, United States
Using Autologous Platelet Rich Plasma (PRP) Gel to Treat Deep 2nd and 3rd Degree Burns
- Conditions
- Acute Burns
- First Posted Date
- 2013-05-01
- Last Posted Date
- 2018-01-09
- Lead Sponsor
- Arteriocyte, Inc.
- Target Recruit Count
- 42
- Registration Number
- NCT01843686
- Locations
- 🇺🇸
University of California, Davis, Division of Burn Surgery, Sacramento, California, United States
🇺🇸Medstar Health Research Institute, Washington, District of Columbia, United States
🇺🇸University of Utah Hospital, Salt Lake City, Utah, United States
Phase I, Arteriocyte Magellan MAR01 Therapy - Compartment Syndrome and Battlefield Trauma
- Conditions
- Compartment Syndrome
- First Posted Date
- 2013-04-23
- Last Posted Date
- 2017-04-13
- Lead Sponsor
- Arteriocyte, Inc.
- Target Recruit Count
- 5
- Registration Number
- NCT01837264
- Locations
- 🇺🇸
Advocate Christ Medical Center, Oak Lawn, Illinois, United States
Safety Study of Bone Marrow Cell Concentrate Prepared Using the Magellan System to Treat Critical Limb Ischemia (CLI)
- Conditions
- Critical Limb Ischemia (CLI)Peripheral Vascular Disease (PVD)
- First Posted Date
- 2011-07-01
- Last Posted Date
- 2017-01-24
- Lead Sponsor
- Arteriocyte, Inc.
- Target Recruit Count
- 18
- Registration Number
- NCT01386216
- Locations
- 🇺🇸
The Ohio State University Medical Center, Columbus, Ohio, United States